OTCMKTS:PURE PURE Bioscience - PURE Short Interest Ratio & Short Volume Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding PURE Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.13 -0.01 (-7.30%) (As of 02/2/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.12▼$0.1550-Day Range$0.08▼$0.1552-Week Range$0.07▼$0.24Volume35,192 shsAverage Volume28,545 shsMarket Capitalization$14.13 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest PURE Bioscience Short Interest DataCurrent Short Volume1,300 sharesPrevious Short Volume400 sharesChange Vs. Previous Month+225.00%Dollar Volume Sold Short$130.00Short Interest Ratio / Days to Cover0.0Last Record DateJanuary 15, 2023Outstanding Shares111,360,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume35,192 sharesAverage Trading Volume28,545 sharesToday's Volume Vs. Average23.29% Short Selling PURE Bioscience ? Sign up to receive the latest short interest report for PURE Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPURE Short Interest Over TimePURE Days to Cover Over TimePURE Percentage of Float Shorted Over Time PURE Bioscience (OTCMKTS:PURE) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20231,300 shares $130.00 +225.0%N/A0 $0.10 12/30/2022400 shares $33.92 -93.8%N/A0 $0.08 12/15/20226,400 shares $851.84 -65.6%N/A0.1 $0.13 11/30/202218,600 shares $2,788.14 +463.6%N/A0.1 $0.15 11/15/20223,300 shares $561.50 -88.5%N/A0.1 $0.17 10/31/202228,600 shares $4,807.66 +5.9%N/A0.3 $0.17 10/15/202227,000 shares $5,211.00 +23.9%N/A1.9 $0.19 9/30/202221,800 shares $4,360.00 +1.4%N/A0.2 $0.20 9/15/202221,500 shares $4,942.85 -40.9%N/A0 $0.23 8/31/202236,400 shares $7,280.00 +23.0%N/A0.2 $0.20 8/15/202229,600 shares $6,808.00 -1.3%N/A0.2 $0.23 7/31/202230,000 shares $5,991.00 +226.1%N/A0.1 $0.20 7/15/20229,200 shares $1,835.40 -72.0%N/A0.2 $0.20 6/30/202232,900 shares $6,251.00 -23.3%N/A0.7 $0.19 6/15/202242,900 shares $8,258.25 -3.2%N/A1.7 $0.19 5/31/202244,300 shares $8,860.00 +23.7%N/A0.9 $0.20 5/15/202235,800 shares $6,798.42 +1,093.3%N/A0.7 $0.19 4/30/20223,000 shares $524.40 -67.4%N/A0.1 $0.17 4/15/20229,200 shares $1,768.70 -75.7%N/A0.1 $0.19 3/31/202237,800 shares $7,182.00 +1,045.5%N/A0.3 $0.19 3/15/20223,300 shares $595.65 -83.8%N/A0.1 $0.18 2/28/202220,400 shares $3,967.80 +100.0%N/A1.4 $0.19 2/15/202210,200 shares $2,036.94 +108.2%N/A0.1 $0.20 1/31/20224,900 shares $1,078.00 +2.1%N/A0.1 $0.22 1/15/20224,800 shares $962.40 +50.0%N/A0 $0.20 12/31/20213,200 shares $610.24 -93.9%N/A0 $0.19 12/15/202152,300 shares $14,293.59 +325.2%N/A0.4 $0.27 11/30/202112,300 shares $4,059.00 +200.0%N/A0.1 $0.33 11/15/20214,100 shares $1,314.05 -70.1%N/A0 $0.32 10/29/202113,700 shares $5,206.00 +291.4%N/A0.2 $0.38 10/15/20213,500 shares $1,174.25 -7.9%N/A0.1 $0.34 9/30/20213,800 shares $1,487.70 -86.9%N/A0.1 $0.39 9/15/202129,100 shares $12,236.55 +419.6%N/A0.2 $0.42 8/31/20215,600 shares $2,024.68 -11.1%N/A0 $0.36 8/13/20216,300 shares $2,387.07 +152.0%N/A0.2 $0.38 7/30/20212,500 shares $1,050.00 No ChangeN/A0.1 $0.42 7/15/20212,500 shares $1,102.75 -30.6%N/A0.1 $0.44 6/30/20213,600 shares $1,638.00 +28.6%N/A0 $0.46 6/15/20212,800 shares $1,343.44 -6.7%N/A0.1 $0.48 5/28/20213,000 shares $1,530.00 +25.0%N/A0 $0.51 PURE Short Interest - Frequently Asked Questions What is PURE Bioscience's current short interest? Short interest is the volume of PURE Bioscience shares that have been sold short but have not yet been closed out or covered. As of January 15th, traders have sold 1,300 shares of PURE short. Learn More on PURE Bioscience's current short interest. Is PURE Bioscience's short interest increasing or decreasing? PURE Bioscience saw a increase in short interest in January. As of January 15th, there was short interest totaling 1,300 shares, an increase of 225.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does PURE Bioscience's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to PURE Bioscience: Artemis Therapeutics Inc. (0.00%), Heart Test Laboratories, Inc. (0.39%), Galmed Pharmaceuticals Ltd. (0.66%), Check-Cap Ltd. (0.43%), Alterity Therapeutics Limited (0.34%), Oncology Pharma Inc. (0.06%), Lucira Health, Inc. (4.04%), AcelRx Pharmaceuticals, Inc. (7.95%), Talis Biomedical Co. (0.98%), and Graybug Vision, Inc. (0.36%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks. What does it mean to sell short PURE Bioscience stock? Short selling PURE is an investing strategy that aims to generate trading profit from PURE Bioscience as its price is falling. PURE shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PURE Bioscience? A short squeeze for PURE Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PURE, which in turn drives the price of the stock up even further. How often is PURE Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PURE, twice per month. The most recent reporting period available is January, 15 2023. More Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PURE) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.